Search Results - "Transou, Andrea"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation by Berezovsky, Artem D, Poisson, Laila M, Cherba, David, Webb, Craig P, Transou, Andrea D, Lemke, Nancy W, Hong, Xin, Hasselbach, Laura A, Irtenkauf, Susan M, Mikkelsen, Tom, deCarvalho, Ana C

    Published in Neoplasia (New York, N.Y.) (01-03-2014)
    “…Abstract The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential for the maintenance of stem cells from early…”
    Get full text
    Journal Article
  2. 2

    Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research by Irtenkauf, Susan M, Sobiechowski, Susan, Hasselbach, Laura A, Nelson, Kevin K, Transou, Andrea D, Carlton, Enoch T, Mikkelsen, Tom, deCarvalho, Ana C

    Published in Comparative medicine (01-08-2017)
    “…Glioblastoma is an aggressive primary brain tumor predominantly localized to the cerebral cortex. We developed a panel of patient-derived mouse orthotopic…”
    Get full text
    Journal Article
  3. 3

    Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry by Hasselbach, Laura A, Irtenkauf, Susan M, Lemke, Nancy W, Nelson, Kevin K, Berezovsky, Artem D, Carlton, Enoch T, Transou, Andrea D, Mikkelsen, Tom, deCarvalho, Ana C

    Published in Journal of visualized experiments (07-01-2014)
    “…Glioblastomas, the most common and aggressive form of astrocytoma, are refractory to therapy, and molecularly heterogeneous. The ability to establish cell…”
    Get full text
    Journal Article
  4. 4

    Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease by Rammo, Richard, Rock, Adam, Transou, Andrea, Raghunathan, Aditya, Rock, Jack

    Published in Journal of neurosurgery (01-02-2016)
    “…Meningiomas are common intracranial tumors categorized as Grades I-III per the current WHO guidelines. A small percentage of meningiomas are Grades II and III,…”
    Get full text
    Journal Article
  5. 5

    CSIG-10. PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA ONCOGENE DEPENDENCY IN GLIOBLASTOMA by Berezovsky, Artem, Datta, Indrani, She, Ruicong, Transou, Andrea, Irtenkauf, Susan, Hasselbach, Laura, Poisson, Laila, deCarvalho, Ana

    Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)
    “…Abstract PDGFRA is the second most frequently amplified gene encoding receptor tyrosine kinase in adult glioblastoma (GBM), oftentimes as extrachromosomal…”
    Get full text
    Journal Article
  6. 6

    CSIG-06. PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA AS AN ONCOGENIC DRIVER IN GLIOBLASTOMA by Berezovsky, Artem, Irtenkauf, Susan, Transou, Andrea, Hasselbach, Laura, Mikkelsen, Tom, de Carvalho, Ana

    Published in Neuro-oncology (Charlottesville, Va.) (09-11-2020)
    “…Abstract Activated platelet derived growth factor receptor alpha (PDGFRα) is essential for the maintenance of oligodendrocyte progenitors. Differential…”
    Get full text
    Journal Article
  7. 7

    Abstract 1505: Platelet derived growth factor receptor alpha oncogene dependency in glioblastoma by Berezovsky, Artem D., Irtenkauf, Susan M., Transou, Andrea D., Hasselbach, Laura A., Mikkelsen, Tom, deCarvalho, Ana C.

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Platelet-derived growth factor receptor alpha (PDGFRA) is a ligand-activated receptor tyrosine kinase (RTK) involved in neurodevelopment. In pediatric…”
    Get full text
    Journal Article
  8. 8

    Abstract 2519: Identification of novel MET fusion transcript amplification in glioblastoma by Nuga, Oluwademilade, deCarvalho, Ana, Meng, Yuling, Hasselbach, Laura, Nelson, Kevin, Irtenkauf, Susan, Transou, Andrea

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Glioblastoma (GBM) is the most common and aggressive primary CNS malignant tumor with a 15.2% 2 year survival rate for tumors diagnosed between 2008…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    TMOD-06. HIGH INCIDENCE OF TUMORS AFTER TREATMENT WITH A DNA-ALKYLATING AGENT IN MOUSE STRAINS COMMONLY USED IN PRE-CLINICAL STUDIES by Irtenkauf, Susan, Hasselbach, Laura, Transou, Andrea, Poisson, Laila, Noushmehr, Houtan, Rybkin, Igor, deCarvalho, Ana

    Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)
    “…Abstract Glioblastoma (GBM) is commonly treated with the DNA-alkylating agent temozolomide (TMZ). Silencing O6-methylguanine-DNA methyltransferase (MGMT) by…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation12 by Berezovsky, Artem D., Poisson, Laila M., Cherba, David, Webb, Craig P., Transou, Andrea D., Lemke, Nancy W., Hong, Xin, Hasselbach, Laura A., Irtenkauf, Susan M., Mikkelsen, Tom, deCarvalho, Ana C.

    Published in Neoplasia (New York, N.Y.) (13-04-2014)
    “…The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential for the maintenance of stem cells from early development to…”
    Get full text
    Journal Article
  15. 15